iSonea, the Maryland-based startup working on smartphone-based asthma monitoring, says it will launch its AirSonea connected hardware device in Australia prior to launching in the US.
The company's AirSonea product, which builds on the company's previous device, the Wheezometer, uses a proprietary sensing method the company calls Acoustic Respiratory Monitoring to monitor an asthma patient's...
iSonea's AsthmaSense App
Medical technology company iSonea has raised $1.05 million in funding from Australian businessman Bruce Mathieson, who now owns about 15 percent of the company.
iSonea's CEO Michael Thomas explained that the funding would help the company build more of its medical devices' functionality into the smartphone platform: "iSonea is committed to developing innovative, non-...
Maryland-based asthma device company, iSonea, makers of the Wheezometer device, recently offered up its first smartphone app, AsthmaSense for iPhone, iPad and Android users. The first iteration of AsthmaSense includes journaling features, medication and testing alert reminders, emergency services contact information, and the ability to share data with caregivers and providers.
Future versions of...
iSonea showed off its wares at HIMSS in the Qualcomm Life booth. The Asthma Sense iPhone app pictured is not yet available in the AppStore.
iSonea, makers of the WheezoMeter, has begun recruiting for a post-market study of its asthma monitoring device for children under the age of 12 years old. The company aims to determine the device's ability to accurately assess wheeze rate in a group of...
iSonea's Wheezometer
Annapolis, Maryland-based asthma monitoring technology company iSonea has inked a deal with Qualcomm Life, a subsidiary of Qualcomm, to combine iSonea's proprietary Acoustic Respiratory Monitoring (ARM) devices and forthcoming mobile health asthma management offerings with Qualcomm's recently launched 2net platform.
The deal will enable users of iSonea's asthma monitoring...
